Poster at the 5th Lipid Nanoparticles Development Summit Europe
17 September 2026 · Berlin
Elissandro Klein, R&D Project Manager, attended the 5th Annual Lipid Nanoparticles Development Summit Europe in Berlin on 23 and 24 September 2026.
He presented Biotech One’s work on the continuous production of lipid-based nanoparticles with supercritical CO₂, and the EncapX® approach to continuous nanoparticle manufacturing.
The company invited people at the summit to talk about continuous manufacturing of lipid-based nanoparticles, supercritical CO₂ processing, and possible collaborations.
Related news
Biotech One pitches EncapX® to France BioLead members
An exclusive member session on 6 November, on bridging R&D formulation and industrial bioproduction for liposome and LNP manufacturing.
5 November 2026
EncapX® presented at the AFSSI webinar
A liposome and LNP formulation platform using supercritical CO₂, to protect fragile molecules and bridge R&D and industrial production.
26 October 2026
EncapX® on stage at World Vaccine Congress Europe 2026
Exhibitor in the Start-up Zone (booth SU3). Talk by Dr Elissandro Klein on continuous scCO₂ processing for vaccine delivery.
21 October 2026 · RAI Amsterdam